Definition
The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.
Description
Morphine is only found in individuals that have used or taken this drug. It is the principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. The precise mechanism of the analgesic action of morphine is unknown. However, specific CNS opiate receptors have been identified and likely play a role in the expression of analgesic effects. Morphine first acts on the mu-opioid receptors. The mechanism of respiratory depression involves a reduction in the responsiveness of the brain stem respiratory centers to increases in carbon dioxide tension and to electrical stimulation.It has been shown that morphine binds to and inhibits GABA inhibitory interneurons. These interneurons normally inhibit the descending pain inhibition pathway. So, without the inhibitory signals, pain modulation can proceed downstream.
Top Gene Interactions
Related Pathways
General Information
- Metabolism: Primarily hepatic (90%), converted to dihydromorphinone and normorphine. Also converted to morphine-3-glucuronide (M3G) and morphine-6-glucuronide. Virtually all morphine is converted to glucuronide metabolites; only a small fraction (less than 5%) of absorbed morphine is demethylated. Route of Elimination: A small amount of glucuronide conjugates are excreted in bile, with minor enterohepatic recycling. Seven to 10% of administered morphine sulfate is excreted in the feces. Half Life: 2-4 hours
- Uses/Sources: For the relief and treatment of severe pain.
- Health Effects: Medical problems can include congested lungs, liver disease, tetanus, infection of the heart valves, skin abscesses, anemia and pneumonia. Death can occur from overdose.
- Symptoms: Symptoms of overdose include cold, clammy skin, flaccid muscles, fluid in the lungs, lowered blood pressure, "pinpoint" or dilated pupils, sleepiness leading to stupor and coma, slowed breathing, and slow pulse rate.
- Treatment: In the treatment of morphine overdosage, primary attention should be given to the re- establishment of a patent airway and institution of assisted or controlled ventilation. Supportive measures (including oxygen, vasopressors) should be employed in the management of circulatory shock and pulmonary edema accompanying overdose as indicated. Cardiac arrest or arrhythmias may require cardiac massage or defibrillation. The pure opioid antagonists, such as naloxone, are specific antidotes against respiratory depression which results from opioid overdose. Naloxone should be administered intravenously; however, because its duration of action is relatively short, the patient must be carefully monitored until spontaneous respiration is reliably re-established. If the response to naloxone is suboptimal or not sustained, additional naloxone may be administered, as needed, or given by continuous infusion to maintain alertness and respiratory function; however, there is no information available about the cumulative dose of naloxone that may be safely administered. (L1712)
- Route of Exposure: Intravenous, Topical, Oral, Intramuscular, Epidural, Rectal. Bioavailability is approximately 30%.
Toxicity
- Carcinogenicity: No indication of carcinogenicity to humans (not listed by IARC).
- Toxicity: LD50: 461 mg/kg (oral, rat) LD50: 600 mg/kg (oral, mouse)
- Lethal Dose: Human lethal dose by ingestion is 120-250 mg of morphine sulfate.
Mechanism of Action
Target Name | Mechanism of Action | References |
---|---|---|
Potassium voltage-gated channel subfamily H member 2 Cytochrome P450 3A4 Multidrug resistance protein 1 Sigma non-opioid intracellular receptor 1 Solute carrier family 22 member 1 Nociceptin receptor Toll-like receptor 4 |
7932535 12699389 15911273 16777416 18788725 20178837 |
|
Mu-type opioid receptor Kappa-type opioid receptor Delta-type opioid receptor |
The precise mechanism of the analgesic action of morphine is unknown. However, specific CNS opiate receptors have been identified and likely play a role in the expression of analgesic effects. The mechanism of respiratory depression involves a reduction in the responsiveness of the brain stem respiratory centers to increases in carbon dioxide tension and to electrical stimulation. |
9686407 22680612 1323679 9873439 12930147 21621410 16682505 22439881 2832603 17139284 14998329 19932964 12699394 16580848 16392810 17887741 8114680 7932177 7739011 16753266 17016423 17145705 16708053 1846918 7739013 8390575 16530171 1846921 9873603 23419026 17656655 1652025 1967312 16678156 16913723 1659636 12502358 8642554 9651168 15055988 22341895 16580639 16650582 1315868 12166947 2567782 2887656 16534251 19627147 16539674 2831363 21684752 21570305 7959748 11000010 9808678 11752352 22995061 8642567 20478711 |